Shopping Cart 0
Cart Subtotal
USD 0

PharmSource - M&A in the Contract Manufacturing Industry: Implications and Outlook - 2018 Edition

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 4995

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 9990

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 14985
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

PharmSource-M&A in the Contract Manufacturing Industry: Implications and Outlook-2018 Edition

Summary

This report is the 2nd edition of our analysis of Mergers and Acquisitions in the contract manufacturing industry. PharmSource is the most definitive, trustworthy source of strategic insight on this topic in the bio/pharmaceutical realm.

Scope

- Helps bio/pharmaceutical manufacturing, development, and supply chain executives understand the implications of M&A activity on their supply base and sourcing options.

- Helps executives at CMOs and associated contract services companies and investors to recognize the significance of M&A activities for the competitive dynamics of the industry and how company strategies must change to address the altering market.

- To gain insights that might enable predictions of the nature and implications of M&A activity in the next three to five years.

Reasons to buy

This 52-page report gives important, expert insight you won't find in any other source. 28 tables and figures throughout the report illustrate major points and trends. This report is required reading for-

- CMOs: market trends, strategic planning, competitive intelligence, performance benchmarking

- Bio/Pharma: supplier performance benchmarking, market trends, competitive intelligence

- Private equity and Stock analysts: target identification and analysis, portfolio company performance benchmarking.

READ MORE

Table Of Content

Scope

Table of Contents

1. Executive Summary 4

2 Objectives and Methodology 5

3 Overview of M&A Activity 2015-2017 6

Target Characteristics 7

Acquirer Characteristics 11

4 Segment Close-Ups of M&A Activity, 2015-2017 15

Dose Manufacturing 15

API-Biologic 18

API-Small Molecule 19

Analytical Services 21

Formulation and Clinical Supplies Manufacturing 24

Packaging 26

5 Valuations 27

6 Facility Acquisitions 29

7 What It Means 36

8 The Outlook for M&A in the Manufacturing Services Industry 39

9 Notes on Methodology 41

10 Appendix 42

Service Acquisitions 2015-2017 42

Bibliography 49

Primary Research-Key Opinion Leaders Cited in this Report 49

About the Authors 50


List Of Figure

List of Figures

Figure 1: Company Acquisitions by Target Service Offering, 2015-2017 7

Figure 2: Company Acquisitions by Target Revenues, 2015-2017 8

Figure 3: Company Acquisitions by Target Ownership, 2015-2017 8

Figure 4: Acquisition Targets by Sophistication of Capabilities 11

Figure 5: Number of Acquisitions by Acquirer's Core Business 12

Figure 6: Number of Acquisitions by Acquirer Ownership 13

Figure 7: Number of Acquisitions by Principal Acquirer Motivation 14

Figure 8: Dose Forms Manufactured by Acquired Dose Manufacturers 15

Figure 9: Pharma CMO Facility Acquisitions, 2015-2017 30


List Of Table

List of Tables

Table 1: CMO Services Businesses Acquired as Part of Larger Deals, 2017 6

Table 2: Company Acquisitions by Target Service and Size, 2015-2017 9

Table 3: Company Acquisitions by Target Service and Ownership, 2015-2017 9

Table 4: Company Acquisitions by Target Market Scope and Size, 2015-2017 10

Table 5: Most Active Acquirers, 2015-2017 13

Table 6: Company Acquisitions of Dose Manufacturers, 2015-2017 16

Table 7: Company Acquisitions of API-Biologic Manufacturers, 2015-2017 19

Table 8: Company Acquisitions of API-Small Molecule Manufacturers, 2015-2017 20

Table 9: Company Acquisitions of Analytical Services, 2015-2017 22

Table 10: Company Acquisitions of Formulation Manufacturers, 2015-2017 25

Table 11: Company Acquisitions of Contract Packagers, 2015-2017 26

Table 12: Services Deals with Known Transaction Value and Multiples, 2015-2017 27

Table 13: Facility Acquisitions by CMOs, 2015-2017 33

Table 14: Most Active Acquirers, 2015-2017 36

Table 15: Acquisitions by PE Firms, 2015-2017 37

Table 16: Potential Targets: API-Biologic (Non-Cell and Gene Therapy) Service Providers 39

Table 17: Potential Targets: API-Biologic (Gene and Cell Therapy Only) Service Providers 40

Table 18: Service Acquisitions, 2015-2017 42

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

CDMO, CMO, Contract Manufacturing Organization, Contract Development and Manufacturing Organzation, Manufacturing, biologic, API manufacture, Active Pharmaceutical Ingredient manufacture, dose manufacture, dosage manufacture, facility acquisition, Acquirer, Target, Merger and Acquisition, Merger, Acquisition, M&A, valuation, private equity


Companies

3SBio

ABC Laboratories

Absorption Systems

Abzena

Acacia Lifesciences

Accucaps

Accuratus Lab Services

Advanced BioScience Laboratories

Advantar Laboratories

Aeras

Agere Pharmaceuticals

AGIC Capital

Ajinomoto

Akorn

Albany Molecular Research Inc. (AMRI)

Alcala Farma

Alcon

Alkermes

Alliance Protein Laboratories

Almac Group

Alphora Research

Altasciences

Amatsigroup

AmatsiQ

American Peptide Company

AMPAC Fine Chemicals

ams Laboratories

Analytical Biochemical Laboratory

Analytical Lab Group

Antibioticos de Leon

Apicore US

Aptuit

Arcadia SGR

Arch Pharmalabs

Arcinova

Ardena Holding

Ardian

Argenta Limited

Arlington Capital Partners

Array BioPharma

Asahi Glass Company

Ash Stevens

Astellas Pharma

AstraZeneca

Audax Private Equity

Aurobindo Pharma

Avara Pharmaceutical Services

Avid Bioservices

Avista Pharma Solutions

Axcellerate Pharma

Axolabs

B & C Group

Bachem

BASF

Bayer

BCM

Bemis Company

Bioclin Research Laboratories

Biocon

BioDuro

Biogaran

Biogen

BIOMEVA

Blanver Farmoquimica

Blue Stream Laboratories

Boehringer Ingelheim

Bora Pharmaceuticals

Brammer Bio

Bristol-Myers Squibb

Bushu Pharmaceuticals

Cambrex Corporation

Cambrex High Point

Cancer Genetics Inc.

Capsugel

Captek Softgel International

CapVest Partners

Carbogen Amcis

Catalent Pharma Solutions

Cathay Capital

Cellca

Celonic

Cenexi

Cerbios Pharma

Charles River Laboratories

Clinical Supplies Management (CSM)

Clinigen Group

CMC Biologics

Cobra Biologics

Co-Formulate Limited

Cognate Bioservices

Coldstream Laboratories

Companhia Brasileira de Esterilizacao

Cook Pharmica

CordenPharma International

Covance

Crucell

Crystallics

CU Chemie Uetikon

Cytovance Biologics

Daiichi Sankyo

Delpharm

Disposable-Lab

Doppel Farmaceutici

DPT Laboratories

EAG Laboratories

Edgewater Capital Partners

Emergent BioSolutions

Epic Pharma

Epirus Biopharmaceuticals

EQT

Eurofins Scientific Group

Euticals Group

Evonik Industries

Evotec

Exova

Experchem Laboratories

F. Hoffmann-La Roche

Famar

Fareva Holding

Fertin Pharma

Forest Laboratories

Formex

Fresenius Kabi Product Partnering

Frontida BioPharm

Gadea Grupo Farmaceutico

Galien LPS

GEA Group

GeneDesign

Generis

Generis Farmaceutica

GHO Capital

Gland Pharma

GlaxoSmithKline

Glycotope

Grand River Aseptic Manufacturing

Great Point Partners

Halo Pharmaceutical

Healix Infusion Therapy

Hitachi Chemical Co.

Hospira

Hovione

Humanwell Healthcare

Idis

IDT Biologika

Impax Laboratories (Inactive)

INC Research

Infa Group

inVentiv Health

IQ Pharmatek

IRIX Pharmaceuticals

Irvine Pharmaceutical Services

Isochem

Johnson Matthey

JSR Corporation

J-Star Research

KBI Biopharma

Kemwell Biopharma

Kremers Urban Pharmaceuticals

Kuecept

LGC

Lisapharma

Livia Group

Lonza Group

Lubrizol Corporation

Lyophilization Services of New England

Mariol Industrial

Marken

MaSThercell

Meda

Medicure

Merck

Merck KGaA

Microbiology & Quality Associates

Microbiology Research Associates

Micro-Macinazione

Millmount Healthcare

Minafin Group

Mitim

Miwana

Molmed

Mylan

Nelson Laboratories

Neuland Laboratories

NextPharma Technologies

Nitto Denko Avecia (Avecia)

Noramco

Novacap Group

Novasep

NuPharm Laboratories

Ology Bioservices (formerly Nanotherapeutics)

Olon

OnTarget Chemistry

Opexa Pharmaceuticals (Inactive)

Orgenesis

PacificGMP

Pamplona Capital Management

Paragon Bioservices

PAREXEL International

Particle Sciences

Partners Group

Patheon

PCI Pharma Services

PCT (Progenitor Cell Therapy)

Permira Advisers

Perrigo Company

Pfizer

PharmaCell

Pharmaceutical Development Services Division

Pharmapak Technologies

Pharmaron

Pharmaron Beijing Co

Pharmatek Laboratories

Pharmaterials

PharmaVize

Pharmorphix (Sigma Aldrich)

Piramal Pharma Solutions

PMC Group

Polpharma

Polypeptide Group

PolyPeptide Laboratories

Porton Fine Chemicals

Powdersize

ProBioGen

Puracap Pharmaceutical

QS Pharma

Quality Compliance Laboratories

Quantum Pharma

Quantum Pharmaceutical

Quotient Clinical

Quotient Sciences

QuVa Pharma

Recipharm

Recro Pharma

Rentschler Biotechnologie

Roche

Ropack Pharma Solutions

Roquette Freres

Rovi (Laboratorios Farmaceuticos Rovi)

R-Tech Ueno

Sandoz

Sanofi

Sartorius

Sartorius Stedim Biotech

Scynexis

Selexis

SeQuent

Serum Institute of India

SGS Life Science Services

Shanghai Fosun Pharmaceutical (Group) Co

Sharp Packaging Services

Shasun Pharmaceuticals

Shenzhen Hepalink Pharmaceutical

Shire

Siegfried Holding

Sinensis Life Sciences

SK Biotek

SK Capital Partners

Smith & Nephew

Sotera Health

Stemedica International

Sterigenics

SteriPack Group

Sterling Pharma Solutions

Strides Shasun (formerly Strides Arcolab)

Sucampo Pharmaceuticals

Suir Pharma

Sun Pharmaceutical Industries

Swander Pace Capital

Swiss Pharma Nigeria

Symbiotec Pharmalab

Synerlab Group

Takeda

Teva Pharmaceutical Industries

TGA Sciences

The Carlyle Group

The Chemistry Research Solution (TCRS)

The Ritedose Corporation

Therapure Biopharma

Thermo Fisher Scientific

TPI Enterprises

Transferra Nanosciences

Transgene

Trilantic Capital Partners

Unimedic Group

Unique Pharmaceuticals

UniTao Pharmaceuticals

United Parcel Service (UPS)

Unither Pharmaceuticals

VGXI

Vibalogics

ViroCyt

Vistin Pharma

vivoPharm Pty

Wacker Chemie

Whitehouse Laboratories

WuXi AppTec

Xceleron

Xcelience

Yegna Manojavam Drugs and Chemicals

Zenotech Laboratories